Drugs, Devices, and Diagnostics
Latest | Media coverage | Commentary | Academic Literature | Legislation | Reports and Government Documents
Covering prescription medicines and medical devices, which includes instruments, implants, scans and tests, as well as screening and health promoting interventions.
Latest
Media coverage
Plunket vax talks ‘ongoing’
Details of how and when Plunket nurses will step into providing childhood immunisations are still being finalised, say Plunket and Te Whatu Ora leaders.
Thousands missing out on bowel cancer screening – study
Thousands of New Zealanders are failing to get proper screening for bowel cancer.
Pharmac proposes widening access to medicine used in the treatment of chronic heart failure
Pharmac is proposing to widen access to a medicine used in the treatment of chronic heart failure.
Commentary
Aotearoa New Zealand Rare Disorders Strategy
The Aotearoa New Zealand Rare Disorders Strategy sets out the direction for the health system to better support people and their whānau living with rare disorders.
Dear Pharmac – do things differently: what David Seymour’s expectations could mean for the drug-buying agency
Associate Health Minister David Seymour’s recent letter of expectations to drug buying agency Pharmac could fundamentally change the way the organisation makes decisions. Some of these changes could also make Pharmac’s job harder and its decisions more unpopular.
Government’s instructions for Pharmac w/ University of Auckland’s Professor Paula Lorgelly: 22nd July, 2024
Last week, Associate Health Minister David Seymour released his letter to Pharmac setting out his expectations for the agency.
Academic Literature
Pharmac should not be criticised simply for being selective and slow about the medicines it funds
Pharmac is often criticised for not funding enough new medicines and for being too slow to determine which ones it will fund. However, being slow and focused is not proof of being too slow or too focused.
Impact of removing prescription co-payments on the use of costly health services: a pragmatic randomised controlled trial
Eliminating a small co-payment appears to have had a substantial effect on patients’ risk of being hospitalised.
How is the Societal Perspective Defined in Health Technology Assessment? Guidelines from Around the Globe
Considering the recent advancements in economic evaluation methods, it is timely to rethink the role of the societal perspective in HTA guidelines and adopt a more comprehensive perspective to include all costs and consequences of healthcare services.
Legislation and Parliament
No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
Reports and Government Documents
Update on cancer drug Keytruda access
Health New Zealand is moving forward implementation planning to ensure a small group of cancer patients can take advantage of free early access to the drug Keytruda shortly ahead of Pharmac starting to fund the medication.
Streamlining the medicines approval process
Streamlining the medicines approval process
Government Policy Statement on Health 2024–2027
The Government Policy Statement on Health 2024-27 is the public statement of what Government expects the health system to deliver and achieve, and how success will be measured, monitored, and reported.
Key issues
HEALTH SERVICES AND SYSTEMS
EQUITY
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI